Implantable Continuous Glucose Monitoring System Safe, Accurate

Share this content:
Implantable Continuous Glucose Monitoring System Safe, Accurate
Implantable Continuous Glucose Monitoring System Safe, Accurate

MONDAY, Nov. 14, 2016 (HealthDay News) -- A new implantable continuous glucose monitoring (CGM) system seems to be safe and accurate for diabetes, according to a study published online Nov. 4 in Diabetes Care.

Jort Kropff, M.D., from the University of Amsterdam, and colleagues studied the Eversense implantable CGM sensor in 71 participants aged 18 years and older with type 1 and type 2 diabetes. Participants used the CGM system at home and in the clinic in a 180-day multinational-multicenter pivotal trail. During eight in-clinic visits, CGM accuracy was assessed with the primary end point of the mean absolute relative difference (MARD) for venous reference glucose values >4.2 mmol/L.

The researchers found that the MARD value against reference glucose values >4.2 mmol/L was 11.1 percent. Overall, 99.2 percent of samples were found to be in the clinically acceptable error zones A and B in Clarke Error Grid Analysis. The CGM system detected 81 percent of hypoglycemic events within 30 minutes. There were no device-related serious adverse events reported during the study.

"Our results indicate the safety and accuracy of this new type of implantable CGM system and support it as an alternative for transcutaneous CGM," the authors write.

Several authors disclosed financial ties to pharmaceutical and medical device companies, including Senseonics, which manufactures Eversense.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »